Apellis Pharmaceuticals, Inc. (APLS)
NASDAQ: APLS · Real-Time Price · USD
17.21
-0.76 (-4.23%)
At close: Mar 20, 2026, 4:00 PM EDT
17.52
+0.31 (1.78%)
After-hours: Mar 20, 2026, 7:54 PM EDT
Apellis Pharmaceuticals Market Cap
Apellis Pharmaceuticals has a market cap or net worth of $2.2 billion as of March 20, 2026. Its market cap has decreased by -30.78% in one year.
Market Cap
2.20B
Enterprise Value
2.21B
1-Year Change
-30.78%
Ranking
Category
Stock Price
$17.21
Market Cap Chart
Since November 9, 2017, Apellis Pharmaceuticals's market cap has increased from $691.10M to $2.20B, an increase of 218.33%. That is a compound annual growth rate of 14.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 2.20B | -30.78% |
| Dec 31, 2025 | 3.18B | -19.93% |
| Dec 31, 2024 | 3.97B | -44.04% |
| Dec 29, 2023 | 7.09B | 24.06% |
| Dec 30, 2022 | 5.72B | 38.54% |
| Dec 31, 2021 | 4.13B | -4.73% |
| Dec 31, 2020 | 4.33B | 121.45% |
| Dec 31, 2019 | 1.96B | 163.72% |
| Dec 31, 2018 | 741.80M | -32.09% |
| Dec 29, 2017 | 1.09B | 58.05% |
| Nov 9, 2017 | 691.10M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Travere Therapeutics | 2.56B |
| Maze Therapeutics | 2.38B |
| Immunome | 2.36B |
| Wave Life Sciences | 2.28B |
| Disc Medicine | 2.26B |
| Day One Biopharmaceuticals | 2.21B |
| Nektar Therapeutics | 2.15B |
| Galapagos NV | 2.14B |